title: Pharmacophore determination of a gp120 C terminal-derived anti-HIV peptide construct interfering with membrane fusion suggesting that processing of the gp120 C terminus is a prelude to fusion.
abstract: A multiple antigen peptide [CLIV; (PTKAKRR1VVQREKR2)4-K2-K-betaA] from the C terminus of the gp120 subunit of HIV Env inhibits Env-mediated cell-to-cell fusion through direct interference with the process (Virology 2000;273:169). We have examined various CLIV analogs using a cell-to-cell fusion assay, receptor binding assays, and molecular modeling to further address the characteristics of the peptide responsible for its anti-HIV activity. We show that (1) CLIV does not interfere with Env binding to CD4 and does not interact with the binding site of Env on CXCR4; (2) CLIV does not inhibit protease activities already reported to play a role in fusion; and (3) the pharmacophore is composed of cleavage site1 with amino acid residues at its C terminal end. Based on our data and on the literature, we propose that CLIV interferes with processing of the gp120 C terminus at site1 by the lymphocyte surface after CD4 binding. Our hypothesis implies that the cleavage region of Env is submitted to a stepwise processing including the known intracellular cleavage of gp160 at site2 in order to set the activation of the fusion peptide and a yet unexplored cleavage at site1 by the target cell surface that triggers fusion.
authors.affiliation: CNRS, Faculté de Médecine Nord, Marseille, France and Institut Universitaire de Sciences Biologiques, Monastir, Tunisia.
authors.forename: R
authors.initials: R
authors.lastname: Barbouche
authors.forename: E
authors.initials: E
authors.lastname: Feyfant
authors.forename: B
authors.initials: B
authors.lastname: Belhaj
authors.forename: E
authors.initials: E
authors.lastname: Fenouillet
mesh_terms: D000595:Amino Acid Sequence; D000998:Antiviral Agents / Q000378:metabolism*; D015704:CD4 Antigens / Q000378:metabolism; D018819:Dipeptidyl Peptidase 4 / Q000378:metabolism; D015699:HIV Envelope Protein gp120 / Q000378:metabolism*; D006801:Humans; D008561:Membrane Fusion; D008969:Molecular Sequence Data; D010455:Peptides / Q000378:metabolism*; D019718:Receptors, CXCR4 / Q000378:metabolism
chemical_list: D000998:Antiviral Agents; D015704:CD4 Antigens; D015699:HIV Envelope Protein gp120; D010455:Peptides; D019718:Receptors, CXCR4; D018819:Dipeptidyl Peptidase 4